Good morning, you're tuned into Markets Desk, let's get you caught up on what's moving.
Ferrari shares have shed a third of their value since July, but the bear case may be overstated. The company continues to demonstrate the kind of pricing power and demand resilience that most automakers can only envy, and analysts who've looked closely argue the selloff has created a genuine disconnect from fundamentals.
Shifting to health care, a weight loss drug developer cratered twenty-five percent after new safety data rattled investors. The experimental compound did hit its primary endpoints, but the side effect profile has analysts questioning whether it can ever command a meaningful commercial footprint — and in the obesity space, a crowded and competitive field, that distinction matters enormously.
Meanwhile, Goldman Sachs is out with a nine-indicator framework assessing whether markets are running dangerously hot. The headline takeaway is nuanced — valuations have drifted closer to bubble territory compared to earlier this year, but the aggregate picture across Goldman's full dashboard is not, in their words, alarming. Elevated, yes. Cause for panic, not yet.
That's the tape. Markets Desk, signing off the floor.
